In my most humble opinion among the most vital and impactful program in the world, which supports prostate cancer research funding and prostate cancer research resources, is in trouble. It is the only government program that funds only prostate cancer research. All of its research funding mechanisms are designed to fund high risk and potentially [...]
The US Senate Appropriations Subcommittee on Defense yesterday marked-up their version of the FY14 Defense Appropriations Act. The full committee is scheduled to mark up tomorrow Thursday). The following is an excerpt from the committee’s summary of the bill: Significant increases to DoD medical research efforts, including: o $200 million for the Peer-Reviewed Medical Research [...]
I have often discussed the importance of the Prostate Cancer Research Program (PCRP), which is a part of the Department of Defense (DOD) Medical Research Program. The program is geared to delivering funding for prostate cancer research that is translational, or will be quickly interpreted in the clinic. Like all other government funding it very [...]
Yesterday May 16, 2012, the House Appropriations Committee released their draft committee report to accompany the FY13 Defense Appropriations Act. This draft included the CDMRP requested budget for 2013. The good news is that the ask includes $80 million dollars for the Prostate Cancer Research Program. Although this is the same amount prostate cancer received [...]
The Prostate Cancer Research Program (PCRP) of the Department of Defense, Congressionally Directed Medical Research Programs (CDMRP) has received our fiscal year 2012 (FY12) funding to support research projects in the prevention, detection, diagnosis, and treatment of Prostate Cancer. This is a critical request and it is important that prostate cancer survivors participate in research [...]